Filing Details
- Accession Number:
- 0001562180-19-006291
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-12-30 17:39:35
- Reporting Period:
- 2019-12-23
- Accepted Time:
- 2019-12-30 17:39:35
- Original Submission Date:
- 2019-12-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741285 | Zoran Zdraveski | C/O Magenta Therapeutics, Inc. 50 Hampshire Street Cambridge MA 02139 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-23 | 9 | $7.71 | 140,101 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-23 | 4,172 | $9.49 | 144,273 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-23 | 4,181 | $16.03 | 140,092 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-24 | 820 | $7.71 | 140,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-24 | 7,902 | $16.00 | 133,010 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-23 | 4,172 | $0.00 | 4,172 | $9.49 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-23 | 9 | $0.00 | 9 | $7.71 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-24 | 820 | $0.00 | 820 | $7.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 129,342 | 2028-05-08 | No | 4 | M | Direct | |
| 17,676 | 2028-01-30 | No | 4 | M | Direct | |
| 16,856 | 2028-01-30 | No | 4 | M | Direct |
Footnotes
- Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise.
- This trade is pursuant to an active 10b5-1 plan.
- This transaction was executed in multiple trades at prices ranging from $16.00 to $16.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $16.00 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Balance has been updated to reflect the shares acquired and sold on the form 4 filed 12/26/2019.
- This option vests and becomes exercisable in 48 equal monthly installments beginning on the date of effectiveness of the Issuer's Registration Statement on Form S-1.
- This option vests and becomes exercisable in 16 equal quarterly installments beginning on January 1, 2018.
Billionaire Hedge Funds
